In the ongoing fight against aggressive brain cancers like glioblastoma, a promising new approach is gaining attention: Boron Neutron Capture Therapy. Despite advances in surgery, chemotherapy, and radiation, survival rates for these tumors remain low, especially when they recur. BNCT offers a new path forward—one that targets cancer cells with remarkable precision while sparing healthy brain tissue.

The therapy works by first delivering a boron-based compound that selectively accumulates in tumor cells. Once in place, the patient is exposed to a beam of neutrons. When these neutrons interact with boron atoms, they trigger a reaction that releases high-energy particles. These particles travel only a microscopic distance—about the size of a single cell—destroying cancer cells from within while leaving surrounding tissue largely unharmed. This level of precision sets BNCT apart from conventional radiotherapy, which often damages both healthy and cancerous cells.

Figure 1. BNCT Technique.

A recent comprehensive review published in Research highlights decades of global clinical studies on BNCT. Led by researchers including Chunhong Wang, Zhigang Liu, and Xiao Xu, the analysis examined outcomes in patients with newly diagnosed and recurrent brain tumors. The findings suggest that BNCT can extend survival and, in some cases, achieve lasting tumor control—particularly in patients whose cancers resist standard treatments. Figure 1 shows BNCT Technique.

One of BNCT’s key strengths lies in its ability to target diverse tumor cell populations, including those in low-oxygen environments that are typically resistant to other therapies. At the same time, boron compounds used in treatment have shown minimal side effects, improved patient tolerance and opening the possibility for repeated treatments.

Beyond gliomas, BNCT is also showing potential in other cancers, including head and neck tumors, melanoma, and certain liver cancers. Advances in technology are further accelerating its development [1]. While early BNCT systems relied on nuclear reactors, newer accelerator-based neutron sources are more compact and suitable for hospital settings, making the therapy more accessible.

Equally important is the impact on quality of life. Compared to traditional treatments, BNCT appears to cause less neurological damage, helping patients maintain cognitive function and daily independence.

While challenges remain—such as standardizing treatment protocols and conducting large-scale clinical trials—the growing body of evidence points to BNCT as a transformative step in cancer care. By combining targeted drug delivery with precise nuclear reactions, it represents a new frontier in oncology—one that could redefine treatment for some of the most difficult cancers.

Reference:

1. https://bioengineer.org/boron-neutron-capture-therapy-a-breakthrough-in-cancer-treatment/

Cite this article:

Keerthana S (2026), Revolutionary BNCT Technique Could Transform Cancer Treatment, AnaTechMaz, pp.454